Hypertensiona | Diabetic nephropathyb | |
Amturnide | X | |
Azor | X | |
Benicar | X^ | O |
Benicar HCT | X | |
Edarbi | X | O |
Edarbyclor | X | |
Tekamlo | X | |
Tekturna | X | |
Tekturna HCT | X | |
Teveten HCT | X | |
Tribenzor | X |
Hypertensiona | Diabetic nephropathyb | |
Amturnide | X | |
Azor | X | |
Benicar | X^ | O |
Benicar HCT | X | |
Edarbi | X | O |
Edarbyclor | X | |
Tekamlo | X | |
Tekturna | X | |
Tekturna HCT | X | |
Teveten HCT | X | |
Tribenzor | X |
OR
Drug | Dosing Regimen | Dose Limit/ Maximum Dose |
---|---|---|
Benazepril | Hypertension | 80 mg/day |
Captopril | Hypertension | 450 mg/day |
Fosinopril | Hypertension | Hypertension |
Lisinopril | Hypertension | Hypertension |
Quinapril | Hypertension | Hypertension |
losartan (CozaarR) | Adult Hypertension 25 - 100 mg PO QD (single or two divided doses) Pediatric Hypertension >/= 6 years: 0.7 mg/kg (up to 50 mg) - 1.4 mg/kg (up to 100 mg) PO QD Hypertension with LVH 50 - 100 mg PO QD Nephropathy 50 - 100 mg PO QD | 100 mg/day |
losartan/HCTZ | Hypertension | 100 mg/25 mg/day |
irbesartan | Hypertension 150 - 300 mg PO QD Nephropathy 300 mg PO QD | 300 mg/day |
irbesartan/HCTZ | Hypertension | 300/25 mg/day |
candesartan | Adult Hypertension 8 - 32 mg PO QD (single or two divided doses) Pediatric Hypertension 1 to <6 years: 0.05 - 0.4 mg/kg PO QD 6 to <17 years (<50 kg): 4 - 16 mg PO QD 6 to <17 years (>50 kg): 4 - 32 mg PO QD Heart Failure 4 - 32 mg PO QD | 32 mg/day |
candesartan/HCTZ | Hypertension | 32/25 mg/day |
eprosartan (Teveten)* | Hypertension: 400 - 800 mg PO QD (single or two divided doses) | This section intentionally left blank. |
telmisartan (Micardis) | Hypertension: 40 - 80 mg PO QD Cardiovascular Risk Reduction: 80 mg PO QD | 80 mg PO QD |
telmisartan/ amlodipine (Twynsta) | Hypertension: 40/5 - 80/10 mg PO QD | 80/10 mg PO QD |
telmisartan/ HCTZ (Micardis HCT) | Hypertension: 40/12.5 - 80/25 mg PO QD | 80/25 mg PO QD |
valsartan (Diovan)* | Hypertension: 80 - 320 mg PO QD Pediatric Hypertension: 6 to 16 years: 1.3 mg/kg (up to 40 mg) - 2.7 mg/kg (up to 160 mg) PO QD Heart Failure: 40 - 160 mg PO BID Post-MI: 20 - 160 mg PO BID | 320 mg PO QD |
valsartan/ HCTZ (Diovan HCT)* | Hypertension: 160/12.5 - 320/25 mg PO QD | 320/25 mg PO QD |
amlodipine/ valsartan (Exforge)* | Hypertension: 5/160 - 10/320 mg PO QD | 10/320 mg PO QD |
amlodipine/ valsartan/ HCTZ (Exforge HCT)* | Hypertension: 5/160/12.5 - 10/320/25 mg PO QD | 10/320/25 mg PO QD |
Drug | Dosing Regimen | Authorization Limit |
---|---|---|
Benicar | Adult Hypertension 20 - 40 mg PO QD Pediatric Hypertension 20 to <35 kg: 10 - 20 mg PO QD >/=35 kg: 20 - 40 mg PO QD | Length of benefit |
Benicar HCT | Hypertension | Length of benefit |
Teveten HCT | Hypertension | Length of Benefit |
Edarbi | Hypertension: 80 mg PO QD; consider 40 mg PO QD for patients on high doses of diuretics | Length of Benefit |
Edarbyclor | Hypertension: 40/12.5 - 40/25 mg PO QD | Length of Benefit |
Amturnide | Hypertension: 150/5/12.5 - 300/10/25 mg PO QD | Length of Benefit |
Azor | Hypertension: Initiate with 5/20 mg PO QD for 1 to 2 weeks; titrate as needed up to 10/40 mg PO QD | Length of Benefit |
Tekamlo | Hypertension: Initiate with 150/5 mg PO QD; titrate as needed up to 300/10 mg PO QD | Length of Benefit |
Tekturna | Hypertension: 150 - 300 mg PO QD | Length of Benefit |
Tekturna HCT | Hypertension: 150/12.5 - 300/25 mg PO QD | Length of Benefit |
Tribenzor | Hypertension: 20/5/12.5 - 40/10/25 mg PO QD | Length of Benefit |